UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 488

Sortiert nach

Primary Sjögren’s syndrome: new clinical and therapeutic concepts

Annals of the Rheumatic Diseases, 2005-03, Vol.64 (3), p.347-354

2005

Volltextzugriff (PDF)

Epigenetic alterations in Sjögren’s syndrome patient saliva

Clinical and experimental immunology, 2020-11, Vol.202 (2), p.137-143

2020

Volltextzugriff (PDF)

Peripheral neuropathies in Sjögren’s syndrome: A critical update on clinical features and pathogenetic mechanisms

Journal of autoimmunity, 2012-08, Vol.39 (1), p.27-33

2012

Volltextzugriff (PDF)

Rates of Convergence for the Three State Contact Process in One Dimension

Journal of statistical physics, 2013-07, Vol.152 (2), p.388-398

Tzioufas, A.

2013

Volltextzugriff (PDF)

Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome

Clinical and experimental immunology, 2015-10, Vol.182 (1), p.14-22

2015

Volltextzugriff (PDF)

Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration

Journal of autoimmunity, 2016-04, Vol.68, p.30-38

2016

Volltextzugriff (PDF)

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis

The European respiratory journal, 2010-07, Vol.36 (1), p.116-121

2010

Volltextzugriff (PDF)

Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment

Annals of the Rheumatic Diseases, 2006-02, Vol.65 (2), p.144-148

2006

Volltextzugriff (PDF)

Toll‐like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway

Clinical and experimental immunology, 2014-12, Vol.178 (3), p.548-560

2014

Volltextzugriff (PDF)

Sjogren’s syndrome: An update on clinical, basic and diagnostic therapeutic aspects

Journal of autoimmunity, 2012-08, Vol.39 (1), p.1-3

2012

Volltextzugriff (PDF)

Lupus thrombocytopenia: clinical implications and prognostic significance

Annals of the rheumatic diseases, 2005-09, Vol.64 (9), p.1366-1369

2005

Volltextzugriff (PDF)

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease

Seminars in arthritis and rheumatism, 2020-10, Vol.50 (5), p.846-853

2020

Volltextzugriff (PDF)

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.732-739

2007

Volltextzugriff (PDF)

Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

Clinical and experimental immunology, 2007-03, Vol.147 (3), p.497-503

2007

Volltextzugriff (PDF)

Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome

Clinical and experimental immunology, 2016-12, Vol.186 (3), p.304-312

2016

Volltextzugriff (PDF)

On the Growth of the One-Dimensional Reverse Immunization Contact Processes

Journal of applied probability, 2011-09, Vol.48 (3), p.611-623

Tzioufas, A.

2011

Volltextzugriff (PDF)

Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts

European journal of clinical investigation, 2004-10, Vol.34 (10), p.690-700

2004

Volltextzugriff (PDF)

Fine specificity of anti‐citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis

Clinical and experimental immunology, 2013-10, Vol.174 (1), p.10-17

2013

Volltextzugriff (PDF)

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Annals of the Rheumatic Diseases, 2011-07, Vol.70 (7), p.1183-1190

2011

Volltextzugriff (PDF)

Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations

Lupus, 2016-10, Vol.25 (11), p.1260-1265

2016

Volltextzugriff (PDF)

The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren’s syndrome

Clinical and experimental immunology, 2002-06, Vol.128 (3), p.562-568

2002

Volltextzugriff (PDF)

Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)

Annals of the rheumatic diseases, 2006-08, Vol.65 (8), p.1033-1037

2006

Volltextzugriff (PDF)

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas

Rheumatology (Oxford, England), 2004-08, Vol.43 (8), p.1050-1053

2004

Volltextzugriff (PDF)

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.294-295

2016

Volltextzugriff (PDF)

Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece

Rheumatology international, 2017-09, Vol.37 (9), p.1441-1452

2017

Volltextzugriff (PDF)

1 – 25 von 488

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(433)
Mit Volltextzugriff
(395)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Primary Sjögren’s syndrome: new clinical and therapeutic concepts

Epigenetic alterations in Sjögren’s syndrome patient saliva

Peripheral neuropathies in Sjögren’s syndrome: A critical update on clinical features and pathogenetic mechanisms

Rates of Convergence for the Three State Contact Process in One Dimension

Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome

Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis

Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment

Toll‐like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway

Sjogren’s syndrome: An update on clinical, basic and diagnostic therapeutic aspects

Lupus thrombocytopenia: clinical implications and prognostic significance

Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome

On the Growth of the One-Dimensional Reverse Immunization Contact Processes

Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts

Fine specificity of anti‐citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis

Preliminary classification criteria for the cryoglobulinaemic vasculitis

Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations

The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren’s syndrome

Long term remission of Sjögren’s syndrome associated aggressive B cell non-Hodgkin’s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece

Suchergebnisse filtern